Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2Phase 4 1Phase 1/2 1

Status

Recruiting 5Completed 3Terminated 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 2Genitourinary 1

Conditions

Brain Neoplasms 2Radiation Injuries 1Prostatic Neoplasms 1Optic Neuritis 1Myelitis, Transverse 1Myelitis 1Myasthenia Gravis 1Glioma 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 91Gemcitabine 81Paclitaxel 79Docetaxel 70Capecitabine 64Oxaliplatin 53Fluorouracil 51Specimen Handling 50Magnetic Resonance Spectroscopy 49Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 45Drug Therapy 39Leucovorin 38Doxorubicin 37Pemetrexed 35Irinotecan 34Injections 30Rituximab 29Vincristine 28Trastuzumab 26Radiosurgery 26Prednisone 26Lenalidomide 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Adrenal Cortex Hormones × Clear all
NCT06925737 2026-05-22

MK-2400-001

Merck Sharp & Dohme LLC

Phase 3 Recruiting
1,440 enrolled
Genitourinary

Prostatic Neoplasms

NCT07100990 2026-05-05

TIMELY-PLEX

Mayo Clinic

Phase 3 Recruiting
382 enrolled

Myelitis, Myelitis, Transverse, Optic Neuritis

NCT06888817 2026-02-25

BRAINS

The Netherlands Cancer Institute

Phase 3 Recruiting
408 enrolled
CNS

Brain Neoplasms, Glioma, Radiation Injuries

NCT06342544 2026-01-21

IMCOMG

Fondation Ophtalmologique Adolphe de Rothschild

Phase 3 Recruiting
128 enrolled

Myasthenia Gravis

NCT06471465 2025-08-17

BRADI

Institut Cancerologie de l'Ouest

Phase 3 Recruiting
84 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡